These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2445410)
1. Effect of salmon calcitonin on symptoms and urinary excretion of 5 hydroxyindoleacetic acid in the carcinoid syndrome. Antonelli A; Del Guerra P; Fierabracci A; Gori E; Baschieri L Br Med J (Clin Res Ed); 1987 Oct; 295(6604):961. PubMed ID: 2445410 [No Abstract] [Full Text] [Related]
2. Treatment of the carcinoid syndrome with somatostatin, salmon calcitonin, or octreotide. Antonelli A; Gambuzza C; Bertoni F; Baschieri L Clin Ther; 1992; 14(2):178-84. PubMed ID: 1377097 [TBL] [Abstract][Full Text] [Related]
3. The relation between vanilyl mandelic acid and 5-hydroxyindoleacetic acid excretion in a patient with a carcinoid tumour. Marshall PB J Pharm Pharmacol; 1966 Nov; 18(11):764-5. PubMed ID: 4382061 [No Abstract] [Full Text] [Related]
4. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors. Feldman JM Gastroenterology; 1978 Dec; 75(6):1109-14. PubMed ID: 309417 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of a carcinoidosis by cyclophosphamide]. Brichant J; Mairesse M Acta Gastroenterol Belg; 1969 Oct; 32(10):761-70. PubMed ID: 5399793 [No Abstract] [Full Text] [Related]
6. Carcinoid tumors--somatostatine in the diagnosis and therapy. Kinova S; Duris I; Kratochvilova E; Ondrejka P; Payer J Bratisl Lek Listy; 2002; 103(3):108-12. PubMed ID: 12190042 [TBL] [Abstract][Full Text] [Related]
13. The carcinoid syndrome: An example due to an ileal polyp. Orr KB Aust N Z J Surg; 1970 Feb; 39(3):268-72. PubMed ID: 4192147 [No Abstract] [Full Text] [Related]
14. Urinary serotonin in the diagnosis of carcinoid tumors. Feldman JM Clin Chem; 1986 May; 32(5):840-4. PubMed ID: 2421946 [TBL] [Abstract][Full Text] [Related]
15. [Excretion of 5-hydroxyindoleacetic acid in normal and pathological conditions]. Fiorentino E; Pietropaolo C; Calì G Clin Chim Acta; 1966 May; 13(5):563-7. PubMed ID: 5962914 [No Abstract] [Full Text] [Related]
16. Effects of somatostatin infusion in four patients with malignant carcinoid syndrome. Quatrini M; Basilisco G; Conte D; Bozzani A; Bardella MT; Bianchi PA Am J Gastroenterol; 1983 Mar; 78(3):149-51. PubMed ID: 6187212 [TBL] [Abstract][Full Text] [Related]
17. Measurement of plasma 5-hydroxyindoleacetic acid in carcinoid disease: an alternative to 24-h urine collections? Degg TJ; Allen KR; Barth JH Ann Clin Biochem; 2000 Sep; 37 ( Pt 5)():724-6. PubMed ID: 11026528 [No Abstract] [Full Text] [Related]
18. Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue. Marsh HM; Martin JK; Kvols LK; Gracey DR; Warner MA; Warner ME; Moertel CG Anesthesiology; 1987 Jan; 66(1):89-91. PubMed ID: 2432806 [No Abstract] [Full Text] [Related]
19. Oat cell carcinoma of the bronchus and the carcinoid syndrome. Salyer DC; Eggleston JC Arch Pathol; 1975 Oct; 99(10):513-5. PubMed ID: 172051 [TBL] [Abstract][Full Text] [Related]
20. [Effect of somatostatin and salmon calcitonin on carcinoid syndrome. A clinical case]. Festa V; Garrone C; Vietti Ramus G; Lisa F; Simone P; Scotti M; Cocchis D; Garrone GC Minerva Chir; 1989 May; 44(9):1429-33. PubMed ID: 2569698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]